Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 8/20 | 0.77 |
| ▸ | CA9 | Q16790 | 8/20 | 0.77 |
| ▸ | CA1 | P00915 | 4/20 | 0.77 |
| ▸ | CA3 | P07451 | 3/20 | 0.77 |
| ▸ | CA4 | P22748 | 3/20 | 0.77 |
| ▸ | CA5A | P35218 | 3/20 | 0.77 |
| ▸ | CA7 | P43166 | 3/20 | 0.77 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.77 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.77 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.77 |
| ▸ | CA2 | P00918 | 2/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.77 |
| ▸ | CA6 | P23280 | 2/20 | 0.77 |
| ▸ | LMNA | P02545 | 1/20 | 0.77 |
| ▸ | SOST | Q9BQB4 | 1/20 | 0.77 |
| ▸ | NPC1 | O15118 | 3/20 | 0.54 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | PGR | P06401 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Coumarin SCHEMBL1090505 | 0.92 | CA12 (0.83) | CA12CA9CA1CA3CA4 | |
| Coumarin SCHEMBL25431834 | 0.92 | CA12 (0.91) | CA12CA9CA1CA3CA4 | |
| Coumarin SCHEMBL19183240 | 0.90 | CA12 (0.95) | CA12CA9CA1CA3CA4 | |
| SCHEMBL7358531 | 0.90 | CA12 (0.95) | CA12CA9CA1CA3CA4 | |
| Coumarin SCHEMBL14744008 | 0.90 | CA12 (0.67) | CA12CA9CA1CA3CA4 | |
| Coumarin SCHEMBL29078087 | 0.89 | CA12 (0.77) | CA12CA9CA1CA3CA4 | |
| Coumarin SCHEMBL314829 | 0.89 | CA9 (0.77) | CA12CA9CA1CA3CA4 | |
| Coumarin SCHEMBL28052953 | 0.88 | CA12 (0.91) | CA12CA9CA1CA3CA4 | |
| Coumarin SCHEMBL7106473 | 0.88 | CA12 (0.91) | CA12CA9CA1CA3CA4 | |
| Coumarin SCHEMBL3441294 | 0.88 | CA12 (1.00) | CA12CA9CA1CA3CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12419956-B2 | Controlled drug release system of photoresponsive nanocarriers, methods of making and using thereof | THE UNIVERSITY OF HONG KONG (CN) | 2025-09-23 | — | — | US | disclosed |
| CN-115427031-B | Controlled drug release systems of light responsive nanocarriers, methods of making and using the same | 香港大学 | 2024-11-19 | — | — | CN | disclosed |
| US-20230124487-A1 | A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE NANOCARRIERS, METHODS OF MAKING AND USING THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2023-04-20 | — | — | US | disclosed |
| EP-4138816-A1 | A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE NANOCARRIERS, METHODS OF MAKING AND USING THEREOF | The University of Hong Kong (CN) | 2023-03-01 | — | — | EP | disclosed |
| CN-115427031-A | Controlled drug release system of photoresponsive nanocarrier, methods of making and using the same | 香港大学 | 2022-12-02 | — | — | CN | disclosed |
| WO-2021213089-A1 | A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE NANOCARRIERS, METHODS OF MAKING AND USING THEREOF | THE UNIVERSITY OF HONG KONG (CN) | 2021-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12419956-B2 | Controlled drug release system of photoresponsive nanocarriers, methods of making and using thereof | ABCB1, STRA6, LIPA | CA12 2594/4885CA9 1935/4885CA1 4374/4885 |
| US-20230124487-A1 | A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE NANOCARRIERS, METHODS OF MAKING AND USING THEREOF | GHRHR, ABCB1, GRPR | CA12 2665/4885CA9 1964/4885CA1 4361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.